You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】美團再考驗百元支持 石藥逆市靠穩挑戰19元 平保購14458 沽21171/ 美團牛64818 熊51383/ 石藥牛59556 熊53269
阿思達克 03-06 10:17
新型肺炎疫情於美國持續惡化,美股隔晚再度重挫,道指收報26121點,收跌969點(或3.5%)。恆指昨收報26767點,升545點(或2.0%),盤中高位升穿26800點。今早一度回吐逾400點,跌穿26400點,失10天線。恆指好倉(牛證及認購權證)昨淨流出逾1.4億港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾7600萬元,反映投資者部署淡倉看跌。昨日恆指牛證街貨重貨區為收回價25900至25999點,而熊證街貨重貨區為收回價27300至27399點。內地A股相對走強,帶動內險股表現。中國平安(02318)由近日的86元以下低位逐步回穩,昨重返89元和10天線以上收市,升幅2.36%,跑贏大市。平保今早隨市整固,於88元以下徘徊,跌幅近2%,失守10天線。昨有約455萬元淨流出其好倉,淡倉同日則有230萬元淨流入。美團點評(03690)創始人兼CEO王興表示,未來十年將加大科研投入,股份昨收復「紅底」,以近全日高位103.5元收市,升4.3%,收復10天和20天線。今早隨市回軟近2%,至101元水平,暫守百元關。昨有逾3700萬元淨流出其好倉,淡倉同日則有逾950萬元淨流入。政治局常務會議中,國家主席習近平強調要加大公共衛生服務、應急物資保障領域投入,帶動醫藥股向上。石藥(01093)昨曾漲半成至19.06元,大成交升破10天、20天和50天線,收市維持3.2%的升幅,報18.72元。今早低開1.8%於18.38元後,跌幅逐步收窄兼倒升,一度迫近19元水平。昨有22萬元淨流出其好倉,淡倉同日則有15萬元淨流入。美國減息後,新地(00016)連日造好,昨以全日高位113.7元收市,升幅2.6%,一舉重越10天和20天線,並重返二月尾公布中期業績前水平。新地旗下天水圍Wetland Seasons Park第二期已獲批預售樓花同意書,計劃本月底前推售。股份今早回1%,暫守112元。昨分別有54萬和17萬元淨流出其好倉和淡倉。瑞通相關認股證之選擇:平保貼價、中短期購14458,行使價:91.88元,2020年7月到期,實際槓桿:12.2倍平保貼價、中短期沽21171,行使價:83.88元,2020年8月到期,實際槓桿:7.5倍新地輕微價外、中短期購14255,行使價:118.8元,2020年6月到期,實際槓桿:12倍新地輕微價外、中短期沽21424,行使價:100元,2020年7月到期,實際槓桿:8.7倍石藥輕微價外、中年期購11716,行使價:21.28元,2020年10月到期,實際槓桿:4.9倍石藥貼價、短期沽12816,行使價:18元,2020年6月到期,實際槓桿:5.6倍美團貼價、短期購13318,行使價:106.1元,2020年5月到期,實際槓桿:7.7倍美團輕微價外、中短期沽21584,行使價:94.28元,2020年6月到期,實際槓桿:6.5倍阿里輕微價外、中短期購22402,行使價:232.8元,2020年8月到期,實際槓桿:7倍阿里貼價、中短期沽18353,行使價:199.8元,2020年7月到期,實際槓桿:6.9倍瑞通相關牛熊證之選擇:恆指牛證58174,收回價:25610點,槓桿比率:36倍恆指熊證53276,收回價:26910點,槓桿比率:27.9倍平保牛證65034,收回價:82.9元,槓桿比率:16.5倍平保熊證53262,收回價:91.8元,槓桿比率:13.9倍新地牛證52876,收回價:105元,槓桿比率:12.7倍新地熊證51779,收回價:118.9元,槓桿比率:10.9倍石藥牛證59556,收回價:17.2元,槓桿比率:7.9倍石藥熊證53269,收回價:20.1元,槓桿比率:8.3倍美團牛證64818,收回價:96.1元,槓桿比率:11.6倍美團熊證51383,收回價:108.6元,槓桿比率:9.4倍融創牛證67326,收回價:40.4元,槓桿比率:7.1倍融創熊證63161,收回價:47.4元,槓桿比率:8.5倍 重要風險通知本結構性產品並無抵押品。結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。閣下投資前應了解產品風險,如有需要應諮詢專業建議。~重要聲明: 以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account